Canada markets close in 2 hours 11 minutes

Tetra Bio-Pharma Inc. (TBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.03000.0000 (0.00%)
As of 01:23PM EST. Market open.
Full screen
Previous Close0.0300
Open0.0300
Bid0.0250 x N/A
Ask0.0300 x N/A
Day's Range0.0250 - 0.0300
52 Week Range0.0150 - 0.2450
Volume2,841,110
Avg. Volume990,120
Market Cap12.701M
Beta (5Y Monthly)1.98
PE Ratio (TTM)N/A
EPS (TTM)-0.1100
Earnings DateFeb 27, 2023 - Mar 03, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The Canadian Press

    Most actively traded companies on the Toronto Stock Exchange

    TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange: Toronto Stock Exchange (20,344.07, up 61.81): Manulife Financial Corp. (TSX:MFC). Financials. Up 16 cents, or 0.67 per cent, to $23.96 on 8.6 million shares. Enbridge Inc. (TSX:ENB). Energy. Up 14 cents, or 0.25 per cent, to $55.50 on 7.1 million shares. Auxly Cannabis Group Inc. (TSX:XLY). Health care. Up half a cent, or 25 per cent, to 2.5 cents on 4.4 million shares. Suncor Energy Inc. (TSX:SU). Energy.

  • CNW Group

    Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission

    Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is providing its shareholders with a regulatory status update on the REDUVO™ New Drug Submission (NDS).

  • CNW Group

    Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean

    Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that the Company has closed the second tranche of its previously announced financing arrangement (the "Financing") with Global Corporate Finance Opportunities 16 (the "Investor"), an investment vehicle advised by Alpha Blue Ocean ("ABO"), pursuant to the terms of an amended and restated subscription agreement dated September 2, 2022